 Connection
Reema Wahdan-Alaswad to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications Reema Wahdan-Alaswad has written about Gene Expression Regulation, Neoplastic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.516 |
|
|
|
-
Wahdan-Alaswad R, Liu B. "Sister" miRNAs in cancers. Cell Cycle. 2013 Dec 15; 12(24):3703-4.
Score: 0.280
-
Wahdan-Alaswad R, Harrell JC, Fan Z, Edgerton SM, Liu B, Thor AD. Metformin attenuates transforming growth factor beta (TGF-?) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer. Cell Cycle. 2016; 15(8):1046-59.
Score: 0.081
-
Wahdan-Alaswad RS, Cochrane DR, Spoelstra NS, Howe EN, Edgerton SM, Anderson SM, Thor AD, Richer JK. Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Horm Cancer. 2014 Dec; 5(6):374-89.
Score: 0.074
-
Wahdan-Alaswad RS, Bane KL, Song K, Shola DT, Garcia JA, Danielpour D. Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin. Mol Cancer Res. 2012 Jun; 10(6):821-33.
Score: 0.063
-
Tan F, Wahdan-Alaswad R, Yan S, Thiele CJ, Li Z. Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma. Cancer Sci. 2013 Dec; 104(12):1586-92.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|